Trump Raises Concern With Claim on Timing of Shot: Virus Update

(Bloomberg) -- A Pfizer Inc. vaccine trial showed promising safety signs after more than 12,000 people received their second of two doses. President Donald Trump said a coronavirus vaccine may be r...